Global In-vitro Diagnostics Market to 2023: High Demand for Personalized Medicine, Inadequate Reimbursements & Competitive Landscape

DUBLIN, Jan. 31, 2019 /PRNewswire/ --

The "Global In-vitro Diagnostics Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

The in-vitro diagnostics market will register a CAGR of almost 7% by 2023.

Global adoption of advanced treatment solutions to gain traction in the market. The use and adoption of in-vitro diagnostics to manage and test for cancer, CVD, and kidney infectious diseases with immunoassay and molecular diagnostic devices are increasing. The availability of advanced treatment care also enables increased adoption rates among healthcare providers.

Market Overview

High demand for personalized medicine

Personalized medicine provides patient care through early diagnosis and risk assessment, thereby decreasing overall treatment costs. Effective treatment care due to personalized medicine encourages pharmaceutical companies to shift toward companion diagnostics with personalized care solutions.

Inadequate reimbursements

Medical reimbursement plays an important role as advanced diagnostic products are expensive. Therefore, reduced reimbursements hinder the usage of these advanced products.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Siemens and Thermo Fisher Scientific, the competitive environment is quite intense. Factors such as the high demand for personalized medicine and the adoption of advanced treatment solutions, will provide considerable growth opportunities to in-vitro diagnostics manufactures.

Abbott, Danaher, F. Hoffmann-La Roche, Quest Diagnostics, Siemens, and Thermo Fisher Scientific are some of the major companies covered in this report.

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

• Preface

PART 03: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 04: MARKET SIZING

• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 06: MARKET SEGMENTATION BY TECHNOLOGY

• Market segmentation by technology
• Comparison by technology
• Immunochemistry
• Molecular diagnostics
  
• Tissue diagnostics
• Hematology
  
• Others
  
• Market opportunity by technology

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

• Geographic segmentation
• Geographic comparison
• Key leading countries
• Market opportunity

PART 09: DRIVERS AND CHALLENGES

PART 10: VENDOR LANDSCAPE

• Landscape disruption
• Competitive scenario

PART 11: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott
• Danaher
• F. Hoffmann-La Roche
• Quest Diagnostics
• Siemens
• Thermo Fisher Scientific
  

For more information about this report visit https://www.researchandmarkets.com/research/4qwvnq/global_invitro?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-in-vitro-diagnostics-market-to-2023-high-demand-for-personalized-medicine-inadequate-reimbursements--competitive-landscape-300787423.html

SOURCE Research and Markets